Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Cell BioEngines, Inc logo — ‘Off-the-Shelf’ Curative Cell Therapies

Cell BioEngines, Inc

‘Off-the-Shelf’ Curative Cell Therapies

Founded 2022 United States New York, United States 3 employees Pre-Seed Total: $1.38M Biotechnology, Health and Wellness

General Information

Company Name Cell BioEngines, Inc
Founded Year 2022
Location United States New York, United States
Employees 3
Industries Biotechnology, Health and Wellness
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Cell BioEngines, Inc. To contact Cell BioEngines, Inc, visit cellbioengines.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cell BioEngines, Inc compare?

A PDF of Cell BioEngines, Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cell BioEngines, Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cell BioEngines, Inc

Cell BioEngines, Inc is a clinical-stage biotech company that aims to revolutionize cancer treatment through the development of 'off-the-shelf' allogenic cell therapies. The company leverages its proprietary Stem-SPACE platform technology to produce clinical-grade cells at scale from 'non-gene-modified' donor derived blood stem cells. The key unmet needs that the company addresses include the limitations in manufacturing scalability and patient-to-patient variability in obtaining immune cell-based therapies, as well as the manufacturing of highly potent cells for solid cancer treatments. Cell BioEngines' Stem-SPACE platform stands out for utilizing human umbilical cord blood stem cells as a single stable source for all cancer therapies, significantly reducing costs and increasing scalability. Founded in 2022 and headquartered in the United States, Cell BioEngines recently secured a $500.00K Pre Seed Round investment from SOSV on 23 April 2024. The company's innovative approach in addressing critical challenges in cancer treatment, coupled with the support of notable investors, positions it as a promising player in the biotechnology industry. For further details, visit www.cellbioengines.com and follow them on www.twitter.com/cell_bioengines.

Business keywords: Cell BioEngines, Biotech Company, Allogenic Cell Therapies, Stem-SPACE Platform, Cancer Cure, Clinical-Stage, Blood Stem Cells, Cell Therapy, Solid Cancers, Umbilical Cord Blood, Immune Cell Therapy, Oncology, Clinical Grade Cells, Stem Cell Therapy, Manufacturing Scalability

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round $250.00K 1
New York Ventures
11 Jul 2024
Pre Seed Round $500.00K 1
SOSV
SOSV
23 Apr 2024
Pre Seed Round $250.00K 1
SOSV
SOSV
11 Aug 2023
Pre Seed Round $275.00K 1
SOSV
SOSV
01 Mar 2023
Grant $100.00K 1
Harvard Innovation Labs
08 Feb 2023

Cell BioEngines, Inc Alternatives & Competitors

View All Alternatives
Cell BioEngines, Inc vs
Garuda Therapeutics
Garuda Therapeutics United States

Creating off-the-shelf, long-term durable blood stem cell therapies

Series B
9 employees
Biotechnology, Health Care
Cell BioEngines, Inc vs
Acepodia
Acepodia United States

POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER

Series D
49 employees
Biotechnology, Health Care
Cell BioEngines, Inc vs
Celularity Inc.
Celularity Inc. United States

A next-gen Biotech company creating off-the-shelf cellular medicines for Cancer, Infectious, and Deg...

Post-IPO Equity
171 employees
Biotechnology, Health Care
Compare Cell BioEngines, Inc vs Celularity Inc.
Also compare with: Cell BioEngines, Inc vs Wugen Wugen Cell BioEngines, Inc vs Tessa Therapeutics Ltd Tessa Therapeutics Ltd View all alternatives

FAQ About Cell BioEngines, Inc

‘Off-the-Shelf’ Curative Cell Therapies
Cell BioEngines, Inc was founded in 2022.
Cell BioEngines, Inc is headquartered in New York, United States.
Cell BioEngines, Inc operates in Biotechnology and Health and Wellness. Its work centres on Cell BioEngines, Biotech Company, Allogenic Cell Therapies and Stem-SPACE Platform.
Cell BioEngines, Inc has approximately 3 employees.
Cell BioEngines, Inc has completed 5 funding rounds, raising a total of $1.38M. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Cell BioEngines, Inc include Garuda Therapeutics, Acepodia, Celularity Inc., Wugen, Prescient Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cell BioEngines, Inc and Garuda Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cell BioEngines, Inc, https://bouncewatch.com/company/cell-bioengines-inc, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout